Carlyle Secured Lending (CGBD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting is scheduled for June 9, 2025, to vote on authorizing the company to issue shares below net asset value (NAV) within the next 12 months, subject to limitations.
The board unanimously recommends approval, citing the need for capital flexibility to support operations, investments, and regulatory compliance.
The proposal allows issuance of up to 25% of outstanding shares below NAV, with no limit on the discount, and would not require further shareholder approval for each issuance.
The board believes this flexibility is crucial for responding to market conditions, maintaining debt ratios, and seizing investment opportunities.
Voting matters and shareholder proposals
The sole proposal is to authorize the sale or issuance of common stock below NAV, effective for 12 months post-approval.
Approval requires a majority of outstanding shares and a majority of non-affiliated shares.
No other business will be conducted at the special meeting.
Procedures for submitting proposals and nominations for the 2026 annual meeting are detailed, with deadlines and requirements specified.
Board of directors and corporate governance
The board, including a majority of independent directors, has approved and recommends the proposal.
Beneficial ownership by directors and officers is disclosed, with no individual holding more than 0.18% of shares.
Recent changes in board composition are noted, with Mr. Hennigan replacing Mr. Jenkins as an interested director after the record date.
Latest events from Carlyle Secured Lending
- Record originations, stable NAV, and new JVs set the stage for higher returns in 2026.CGBD
Q4 202525 Feb 2026 - Q3 2024 delivered $0.47/share NII, $16.85 NAV/share, and a pending merger with CSL III.CGBD
Q3 20243 Feb 2026 - Q2 net investment income was $0.51/share, NAV $16.95, and a merger with CSL III was announced.CGBD
Q2 20242 Feb 2026 - Q4 net investment income held steady as portfolio, liquidity, and dividend coverage strengthened.CGBD
Q4 202423 Dec 2025 - Vote sought to authorize share issuance below NAV for up to 25% of shares over 12 months.CGBD
Proxy Filing1 Dec 2025 - Stockholders will vote on two director nominees and auditor ratification, with Board support.CGBD
Proxy Filing1 Dec 2025 - Annual proxy outlines voting items and governance, with no filing fee required.CGBD
Proxy Filing1 Dec 2025 - Definitive proxy statement filed for annual meeting with key proposals for shareholder vote.CGBD
Proxy Filing1 Dec 2025 - CSL III merger and portfolio growth offset earnings pressure from lower yields and rising non-accruals.CGBD
Q1 202525 Nov 2025